|
|
|
Volumn 26, Issue 1 SUPPL. 3, 1999, Pages 10-16
|
|
Review of docetaxel and doxorubicin-based combinations in the management of breast cancer: From metastatic to adjuvant setting
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG EFFICACY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
MUCOSA INFLAMMATION;
NEUROPATHY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0033063332
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (17)
|
